With supplier issue now resolved, the Minnesota-run medtech company expects to “reach and then exceed” market growth in the ...

Medtronic stock slumped early Tuesday despite beating fiscal second-quarter expectations after a supplier issue impacted its cardiac ablation division. Please watch the video at Investors.com - How To ...

Atlanta-based Northside Hospital has treated its first patient using Medtronic's PulseSelect pulsed field ablation system for treating paroxysmal or persistent atrial fibrillation. The device, which ...

Medtronic — the world's largest medical device company — is preparing for potential new import taxes and other policy changes ...

Diabetes shines, cardiac ablation stumbles, and new products spark hope--Medtronic's Q2 FY25 shakes up expectations.

Abbott’s Amulet IDE trial put its left atrial appendage closure device up against the Watchman 2.5, which was approved by the ...

This important work advances our understanding of CHMP5's role in regulating osteogenesis through its impact on cellular senescence. The evidence supporting the conclusion is mostly convincing, ...

From its cardiovascular divisions, Medtronic brought in $3.10 billion for an increase of 6.1%—driven in part by the launches ...

When Tara Garcia was born, her skin was tinted blue. This meant a lack of oxygen in her body. Doctors told her parents the ...

Delivering on commitments, executing ahead of expectations, and raising guidanceInnovation driving sustained growth across many franchises: TAVR, PFA, Leadless Pacemakers, Diabetes, Spine ...

The trial data provided clinical evidence indicating that LAAC with the WATCHMAN FLX device is safe and superior to oral anticoagulation (OAC) therapy for reducing the risk of long-term bleeding ...

Medtronic is raising its full-year guidance following second-quarter results that came in ahead of the consensus forecast.